S642-0125 Screening compound: N~1~-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl]-2-(1-oxo-3-phenyl-2-azaspiro[3.5]non-2-yl)acetamide

S642-0125 Screening compound: N~1~-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl]-2-(1-oxo-3-phenyl-2-azaspiro[3.5]non-2-yl)acetamide
S642-0125 Screening compound: N~1~-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl]-2-(1-oxo-3-phenyl-2-azaspiro[3.5]non-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S642-0125
N~1~-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl]-2-(1-oxo-3-phenyl-2-azaspiro[3.5]non-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S642-0125

Molecular Formula

C24H32N4O2 (C24 H32 N4 O2)

Compound Name

N~1~-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methyl]-2-(1-oxo-3-phenyl-2-azaspiro[3.5]non-2-yl)acetamide

IUPAC name

n/a

SMILES

CCn1nc(C)c(CNC(CN(C(C23CCCCC3)c3ccccc3)C2=O)=O)c1C

InChI

InChI=1S/C24H32N4O2/c1-4-28-18(3)20(17(2)26-28)15-25-21(29)16-27-22(19-11-7-5-8-12-19)24(23(27)30)13-9-6-10-14-24/h5,7-8,11-12,22H,4,6,9-10,13-16H2,1-3H3,(H,25,29)/t22-/m0/s1

InChI Key

MBENRFPQIAIBRT-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD29015741

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.54

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.108

Distribution Coefficient, logD

3.108

Water Solubility, LogSw

-3.14

Polar Surface Area

54.924

Acid Dissociation Constant (pKa)

13.53

Base Dissociation Constant (pKb)

2.69

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.20

S642-0125 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S642-0125 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S642-0125?
Check Price and Availability of S642-0125, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S642-0125 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S642-0125
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S642-0125
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S642-0125 available by request